497116146	497116146	CD	B-NP	O
|	|	NNP	I-NP	O
SFMC	SFMC	NNP	I-NP	O
|	|	VBD	B-VP	O
71812853	71812853	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3499457	3499457	CD	B-NP	O
|	|	CC	I-NP	O
3/12/2006	3/12/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NNP	I-NP	I-protein
,	,	,	O	O
Atrial	Atrial	NNP	B-NP	O
Fibrillation	Fibrillation	NNP	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/12/2006	3/12/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/18/2006	5/18/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	B-protein
TELTSCHIK	TELTSCHIK	NNP	B-NP	I-protein
,	,	,	O	O
SANTIAGO	SANTIAGO	NNP	B-NP	O
904-59-50-7	904-59-50-7	CD	I-NP	O
Gene	Gene	NNP	I-NP	O
A	A	NNP	I-NP	O
Fay	Fay	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/4/06	10/4/06	CD	B-NP	O
AT	AT	NN	I-NP	O
06	06	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HOKAMA	HOKAMA	NN	B-NP	O
,	,	,	O	O
CRISTOBAL	CRISTOBAL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/12/06	7/12/06	CD	B-NP	O
by	by	IN	B-PP	O
GOZA	GOZA	NNP	B-NP	O
,	,	,	O	O
CARL	CARL	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
8	8	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
395034051	395034051	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/12/06	7/12/06	CD	B-NP	O
by	by	IN	B-PP	O
COSLAN	COSLAN	NNP	B-NP	O
,	,	,	O	O
ELTON	ELTON	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H	M.P.H	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
8	8	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
404275443	404275443	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/15/06	10/15/06	CD	B-NP	O
by	by	IN	B-PP	O
WILLIAMSEN	WILLIAMSEN	NNP	B-NP	O
,	,	,	O	O
MYRON	MYRON	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H	M.P.H	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
682676058	682676058	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	B-protein
,	,	,	O	O
pt	pt	NN	B-NP	O
on	on	IN	B-PP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

AMIODARONE	AMIODARONE	NN	B-NP	B-protein
200	200	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/3/06	8/3/06	CD	B-NP	O
by	by	IN	B-PP	O
ROEN	ROEN	NNP	B-NP	O
,	,	,	O	O
ANTON	ANTON	NNP	B-NP	O
D	D	NNP	I-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H	M.P.H	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	O
NORVASC	NORVASC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Avoid	Avoid	JJ	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

CALCITRIOL	CALCITRIOL	NN	B-NP	O
0.25	0.25	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
EVERY	EVERY	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DAY	DAY	NNP	I-NP	O
EZETIMIBE	EZETIMIBE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/15/06	10/15/06	CD	B-NP	O
by	by	IN	B-PP	O
PITCAK	PITCAK	NNP	B-NP	O
,	,	,	O	O
CORTEZ	CORTEZ	NNP	B-NP	O
D	D	NNP	I-NP	O
V.	V.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H	M.P.H	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
EZETIMIBE	EZETIMIBE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
986457581	986457581	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
EZETIMIBE	EZETIMIBE	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-	-	HYPH	O	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
80	80	CD	I-NP	O
MG	MG	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
sick/fatigue	sick/fatigue	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	O
PROSCAR	PROSCAR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FINASTERIDE	FINASTERIDE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BPH	BPH	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/13	7/13	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
GLUCOMETER	GLUCOMETER	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
EA	EA	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
GLYBURIDE	GLYBURIDE	NNP	B-NP	I-protein
15	15	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
AVAPRO	AVAPRO	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
IRBESARTAN	IRBESARTAN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
300	300	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QAM	QAM	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/12/06	7/12/06	CD	B-NP	O
by	by	IN	B-PP	O
CHIOU	CHIOU	NNP	B-NP	O
,	,	,	O	O
ABDUL	ABDUL	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
464336501	464336501	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
IRBESARTAN	IRBESARTAN	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
<	<	SYM	B-VP	O
50	50	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
SL	SL	NN	I-NP	I-protein
Q5MIN	Q5MIN	NN	I-NP	I-protein
X	X	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
doses	dose	VBZ	B-VP	O
PRN	PRN	NNP	B-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-DNA
<	<	SYM	O	I-DNA
100	100	CD	B-NP	I-DNA
PRAVASTATIN	PRAVASTATIN	NN	I-NP	I-DNA
80	80	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BEDTIME	BEDTIME	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/12/06	7/12/06	CD	B-NP	O
by	by	IN	B-PP	O
LANGKABEL	LANGKABEL	NN	B-NP	O
,	,	,	O	O
JULES	JULES	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MULTIVITAMIN	MULTIVITAMIN	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
044472178	044472178	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/12/06	7/12/06	CD	B-NP	O
by	by	IN	B-PP	O
RABAGO	RABAGO	NNP	B-NP	O
,	,	,	O	O
RUSTY	RUSTY	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
8	8	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
395034051	395034051	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NN	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/12/06	7/12/06	CD	B-NP	O
by	by	IN	B-PP	O
SARDI	SARDI	NNP	B-NP	O
,	,	,	O	O
LEO	LEO	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H	M.P.H	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
8	8	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
404275443	404275443	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NN	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/15/06	10/15/06	CD	B-NP	O
by	by	IN	B-PP	O
VAIL	VAIL	NNP	B-NP	O
,	,	,	O	O
ADALBERTO	ADALBERTO	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H	M.P.H	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
682676058	682676058	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NN	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	B-protein
,	,	,	O	O
pt	pt	NN	B-NP	O
on	on	IN	B-PP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/15/06	10/15/06	CD	B-NP	O
by	by	IN	B-PP	O
MESSINA	MESSINA	NN	B-NP	O
,	,	,	O	O
EMANUEL	EMANUEL	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H	M.P.H	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
PRAVASTATIN	PRAVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
585668687	585668687	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
EZETIMIBE	EZETIMIBE	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-	-	HYPH	O	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
80	80	CD	I-NP	O
MG	MG	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
sick/fatigue	sick/fatigue	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	O
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVI	MULTIVI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/12/06	7/12/06	CD	B-NP	O
by	by	IN	B-PP	O
VANRULER	VANRULER	NNP	B-NP	O
,	,	,	O	O
WARD	WARD	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6	6	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
follow	follow	VBP	B-VP	O
coumadin	coumadin	NN	B-NP	O
clinic	clinic	NN	I-NP	O
instructions	instruction	NNS	I-NP	O
for	for	IN	B-PP	O
changing	change	VBG	B-NP	O
coumadin	coumadin	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

Thank	Thank	VB	B-VP	O
you	you	PRP	B-NP	O
.	.	.	O	O

Food/Drug	Food/Drug	NN	B-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/3/06	8/3/06	CD	B-NP	O
by	by	IN	B-PP	O
SHUSTER	SHUSTER	NNP	B-NP	O
,	,	,	O	O
EMERY	EMERY	NNP	B-NP	O
W	W	NNP	I-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H	M.P.H	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
AMIODARONE	AMIODARONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
979691335	979691335	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/12/06	7/12/06	CD	B-NP	O
by	by	IN	B-PP	O
KEATY	KEATY	NNP	B-NP	O
,	,	,	O	O
ELTON	ELTON	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/15/06	10/15/06	CD	B-NP	O
by	by	IN	B-PP	O
GOODMAN	GOODMAN	NNP	B-NP	O
,	,	,	O	O
FLETCHER	FLETCHER	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H	M.P.H	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	B-protein
,	,	,	O	O
pt	pt	NN	B-NP	O
on	on	IN	B-PP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
AMC	AMC	NN	B-NP	B-protein
ANTICOAG	ANTICOAG	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
204	204	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
273-3408	273-3408	CD	I-NP	O
CLINIC	CLINIC	NN	I-NP	O
WILL	WILL	MD	B-VP	O
CONTACT	CONTACT	NN	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Emmett	Emmett	NNP	I-NP	O
T	T	NNP	I-NP	O
Tanner	Tanner	NNP	I-NP	O
Alford	Alford	NNP	I-NP	O
051-469-9935	051-469-9935	CD	I-NP	O
5/5/06	5/5/06	CD	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
URNESS	URNESS	NNP	B-NP	O
,	,	,	O	O
CARL	CARL	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DCTMH	DCTMH	NNP	I-NP	O
10/1/2006	10/1/2006	CD	I-NP	O
16	16	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
,	,	,	O	O
Primary	Primary	JJ	B-NP	O
care	care	NN	I-NP	O
:	:	:	O	O
Derick	Derick	NNP	B-NP	O
Lefebre	Lefebre	NNP	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
7/11/06	7/11/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
clinic	clinic	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
PSEUDOEPHEDRINE	PSEUDOEPHEDRINE	NN	B-NP	O
,	,	,	O	O
ACE	ACE	NNP	B-NP	O
Inhibitor	Inhibitor	NNP	I-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
,	,	,	O	O
EZETIMIBE	EZETIMIBE	NNP	B-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
-	-	HYPH	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
80	80	CD	I-NP	O
MG	MG	NN	I-NP	O
,	,	,	O	O
FOSINOPRIL	FOSINOPRIL	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
AF	AF	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
RVR	RVR	NN	I-NP	B-protein
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
,	,	,	O	O
Atrial	Atrial	NNP	B-NP	O
Fibrillation	Fibrillation	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
NIDDM	NIDDM	NN	I-NP	O
HTN	HTN	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
obesity	obesity	NN	I-NP	O
carpal	carpal	JJ	I-NP	O
tunnel	tunnel	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CXR	CXR	NNP	I-NP	O
3/27	3/27	CD	I-NP	O
opacity	opacity	NN	I-NP	O
in	in	IN	B-PP	O
LLL	LLL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
edema	edema	NN	I-NP	O
vs	vs	CC	O	O
atelectasis	atelectasis	NN	B-NP	O
vs	vs	IN	B-PP	O
infiltrate	infiltrate	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CXR	CXR	NN	I-NP	O
8/7	8/7	CD	I-NP	O
likely	likely	JJ	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
in	in	IN	B-PP	O
left	left	JJ	B-NP	O
base	base	NN	I-NP	O
ECHO	ECHO	NN	I-NP	O
10/24	10/24	CD	B-NP	O
EF	EF	NN	I-NP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
inferior/post	inferior/post	NN	B-NP	O
akinesis	akinesis	NN	I-NP	O
,	,	,	O	O
LAE	LAE	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
5cm	5cm	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
TR/MR	TR/MR	NN	I-NP	B-protein
MIBI	MIBI	NNP	I-NP	O
:	:	:	O	O
2/25	2/25	CD	B-NP	O
EF	EF	NN	I-NP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
old	old	JJ	B-NP	O
IMI	IMI	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
8/3	8/3	CD	I-NP	I-protein
improved	improve	VBN	I-NP	O
edema/effusions	edema/effusion	NNS	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
************	************	SYM	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
62	62	CD	B-NP	O
M	M	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
CAD	CAD	NN	I-NP	O
-LRB-	-LRB-	SYM	I-NP	O
old	old	JJ	I-NP	O
IMI	IMI	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
NIDDM	NIDDM	NNP	B-NP	O
,	,	,	O	O
Tob	Tob	NNP	B-NP	B-protein
,	,	,	O	O
PAF	PAF	NN	B-NP	B-protein
,	,	,	O	O
CRF	CRF	NN	B-NP	B-protein
now	now	RB	B-ADVP	O
p/w	p/w	VBP	B-VP	O
~	~	NN	B-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
progressive	progressive	JJ	I-NP	O
DOE	DOE	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
24	24	CD	B-NP	O
hr	hr	NN	I-NP	O
severe	severe	JJ	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
of	of	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
called	call	VBN	B-VP	O
EMS	EMS	NNP	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
c/o	c/o	VBP	B-VP	O
48	48	CD	B-NP	O
hours	hour	NNS	I-NP	O
shaking	shake	VBG	B-VP	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
anorexia	anorexia	NN	B-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
abd	abd	NN	B-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
LE	LE	NN	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
Afib	Afib	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
RVR	RVR	NN	I-NP	B-protein
-LRB-	-LRB-	SYM	B-NP	O
100-150	100-150	CD	B-NP	O
per	per	IN	B-PP	O
EMS	EMS	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
ASA	ASA	NNP	B-NP	O
,	,	,	O	O
NTG	NTG	NNP	B-NP	O
,	,	,	O	O
Dilt	Dilt	NNP	B-NP	O
IV	IV	CD	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
enz	enz	NN	I-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
known	known	JJ	I-NP	O
COPD	COPD	NN	I-NP	O
although	although	IN	B-SBAR	O
25	25	CD	B-NP	O
pkyr	pkyr	NN	I-NP	O
smoking	smoking	NN	I-NP	O
.	.	.	O	O

************	************	SYM	O	O
Admission	Admission	NN	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
98	98	CD	B-NP	O
,	,	,	I-NP	O
128/60	128/60	CD	I-NP	O
,	,	,	I-NP	O
84-104	84-104	CD	I-NP	O
,	,	,	O	O
3L	3L	NN	B-NP	O
CPAP	CPAP	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
GEN	GEN	NN	I-NP	O
:	:	:	O	O
mild	mild	JJ	B-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
OBESE	OBESE	NN	B-NP	B-protein
,	,	,	O	O
pleasant	pleasant	NN	B-NP	O
,	,	,	O	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
PERL	PERL	NN	B-NP	B-protein
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
LUNGS	LUNGS	NN	I-NP	O
:	:	:	O	O
Crackles	Crackles	NNP	B-NP	O
~	~	VBZ	B-VP	O
1/3	1/3	CD	B-NP	O
up	up	RB	I-NP	O
bilat	bilat	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
irregular	irregular	JJ	B-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	O
EXT	EXT	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
LE	LE	NN	I-NP	O
edema	edema	SYM	B-NP	O
bilat	bilat	NN	I-NP	O
************	************	SYM	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
SYSTEM	SYSTEM	NN	I-NP	O
:	:	:	O	O
--	--	:	O	O
CV	CV	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

-LSB-	-LSB-	SYM	O	O
I	I	PRP	B-NP	O
-RSB-	-RSB-	VBP	B-VP	O
--	--	:	O	O
Unlikely	Unlikely	JJ	B-NP	O
ACS	ACS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
no	no	DT	B-NP	O
suspicious	suspicious	JJ	I-NP	O
ECG	ECG	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
enz	enz	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
'd	'd	MD	O	O
ASA	ASA	NNP	B-NP	O
,	,	,	O	O
CCB	CCB	NN	B-NP	B-protein
,	,	,	O	O
BB	BB	NN	B-NP	B-protein
,	,	,	O	O
ARB	ARB	NN	B-NP	B-protein
,	,	,	O	O
restarted	restart	VBD	B-VP	O
statin	statin	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
Pravastatin	Pravastatin	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
ezetimibe	ezetimibe	NN	B-NP	O
for	for	IN	B-PP	O
LDL	LDL	NN	B-NP	B-protein
at	at	IN	B-PP	O
140	140	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

-LSB-	-LSB-	NN	B-NP	B-protein
P	P	NN	I-NP	I-protein
-RSB-	-RSB-	NN	I-NP	I-protein
--	--	:	O	O
EF	EF	NN	B-NP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
4/6	4/6	CD	B-NP	O
MIBI	MIBI	NNP	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
echo	echo	NN	B-NP	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
and	and	CC	I-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
.	.	.	O	O

Responded	Respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
diuresis	diuresis	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
.	.	.	O	O

Was	Wa	NNS	B-NP	B-protein
transitioned	transitione	VBN	B-VP	O
to	to	TO	B-PP	O
PO	PO	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

Fluid	Fluid	NN	B-NP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
<	<	JJR	B-NP	O
2L	2L	NN	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	B-protein
CXR	CXR	NN	I-NP	I-protein
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
improved	improve	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
edema	edema	NN	B-NP	O
lessened	lessen	VBD	B-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

-LSB-	-LSB-	JJ	B-NP	B-protein
R	R	NN	I-NP	I-protein
-RSB-	-RSB-	NN	I-NP	I-protein
--	--	:	O	O
AF	AF	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
RVR	RVR	NN	B-NP	B-protein
,	,	,	O	O
rate	rate	NN	B-NP	O
controlled	control	VBN	B-VP	O
on	on	IN	B-PP	O
BB	BB	NN	B-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
sometimes	sometimes	RB	B-ADVP	O
in	in	IN	B-PP	O
low	low	JJ	B-NP	O
100s	100	NNS	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
this	this	DT	B-NP	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
to	to	TO	B-VP	O
start	start	VB	I-VP	O
amiodarone	amiodarone	NN	B-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
and	and	CC	O	O
pt	pt	NN	B-NP	O
tolerated	tolerate	VBD	B-VP	O
this	this	DT	B-NP	O
well	well	RB	I-NP	O
.	.	.	O	O

Still	Still	RB	B-ADVP	O
in	in	IN	B-PP	O
Afib	Afib	NN	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
rate	rate	NN	B-NP	O
in	in	IN	B-PP	O
80s	80	NNS	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
f/u	f/u	VB	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	O	O
Dr.	Dr.	NNP	B-NP	O
Kaewprasert	Kaewprasert	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
outpt	outpt	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
in	in	IN	B-PP	O
4-6	4-6	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
still	still	RB	B-ADVP	O
in	in	IN	B-PP	O
Afib	Afib	NNP	B-NP	O
will	will	MD	B-VP	O
consider	consider	VB	I-VP	O
electrically	electrically	RB	B-ADVP	O
cardioverting	cardioverte	VBG	B-VP	O
.	.	.	O	O

--	--	:	O	O
PULM	PULM	NN	B-NP	O
:	:	:	O	O
OSA	OSA	NN	B-NP	O
on	on	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
'd	'd	MD	B-NP	O
CPAP	CPAP	NN	I-NP	B-protein
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
transitioned	transitione	VBN	B-VP	O
from	from	IN	B-PP	O
NC	NC	NN	B-NP	B-cell_type
to	to	TO	B-PP	O
RA	RA	NN	B-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

--	--	:	O	O
HEME/ID	HEME/ID	NN	B-NP	O
:	:	:	O	O
Blood/Urine	Blood/Urine	NN	B-NP	O
cx	cx	NN	I-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

Stopped	Stop	VBN	B-NP	O
Abx	Abx	NN	I-NP	B-protein
after	after	IN	B-PP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Levoflox	Levoflox	NNP	B-NP	O
in	in	IN	B-PP	O
ED	ED	NNP	B-NP	O
.	.	.	O	O

UA	UA	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
.	.	.	O	O

Did	Do	VBD	B-VP	O
not	not	RB	I-VP	O
seem	seem	VB	I-VP	O
clinically	clinically	RB	B-ADJP	O
infected	infected	JJ	B-NP	O
given	give	VBN	I-NP	O
CXR	CXR	NN	I-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
questionable	questionable	JJ	B-NP	O
opacity	opacity	NN	I-NP	O
post-diuresis	post-diuresis	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
initially	initially	RB	B-ADVP	O
3.3	3.3	CD	B-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
Coumadin	Coumadin	NNP	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

Restarted	Restart	VBN	B-VP	O
when	when	WRB	B-ADVP	O
<	<	SYM	B-NP	O
3.0	3.0	CD	I-NP	O
.	.	.	O	O

Cont	Cont	JJ	B-NP	O
home	home	NN	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
for	for	IN	B-PP	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
2.0-3	2.0-3	CD	B-NP	O
.0	.0	CD	I-NP	O
.	.	.	O	O

--	--	:	O	O
FEN/GI	FEN/GI	NN	B-NP	O
:	:	:	O	O
ADA	ADA	NN	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Elevated	Elevated	NNP	B-NP	O
LFTs	LFTs	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Bili	Bili	NNP	I-NP	O
1.3	1.3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
likely	likely	RB	B-ADJP	O
from	from	IN	B-PP	O
heart	heart	NN	B-NP	B-protein
failure	failure	NN	I-NP	I-protein
backup	backup	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
now	now	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

--	--	:	O	O
RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
Cr	Cr	NN	B-NP	O
1.6	1.6	CD	I-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
Cr	Cr	NN	I-NP	O
was	be	VBD	B-VP	O
as	as	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
as	as	IN	B-PP	O
1.9	1.9	CD	B-NP	O
.	.	.	O	O

--	--	:	O	O
ENDO	ENDO	NN	B-NP	O
:	:	:	O	O
A1C	A1C	NN	B-NP	B-protein
was	be	VBD	B-VP	O
5.7	5.7	CD	B-NP	O
.	.	.	O	O

Patient	Patient	NNP	B-NP	O
's	's	POS	B-NP	O
outpt	outpt	JJ	I-NP	O
glyburide	glyburide	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
given	give	VBN	B-VP	O
renal	renal	JJ	B-NP	O
dysfxn	dysfxn	NN	I-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
basal	basal	JJ	I-NP	O
and	and	CC	I-NP	O
SS	SS	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
and	and	CC	I-VP	O
titrated	titrate	VBN	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
Glyburide	Glyburide	NN	B-NP	O
and	and	CC	O	O
daily	daily	JJ	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
recommend	recommend	VB	I-VP	O
switching	switch	VBG	B-VP	O
to	to	TO	B-PP	O
glipizide	glipizide	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
will	will	MD	B-VP	O
defer	defer	VB	I-VP	O
to	to	TO	B-PP	O
PCP	PCP	NN	B-NP	B-DNA
.	.	.	O	O

--	--	:	O	B-protein
NEURO/PAIN	NEURO/PAIN	NN	B-NP	I-protein
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

--	--	:	O	O
PROPHY	PROPHY	NN	B-NP	O
:	:	:	O	O
PPI	PPI	NN	B-NP	B-protein
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
--	--	:	O	O
GU	GU	NN	B-NP	O
:	:	:	O	O
BPH	BPH	NN	B-NP	O
--	--	:	O	O
finasteride	finasteride	NN	B-NP	O
--	--	:	O	O
CODE	CODE	NN	B-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
--	--	:	O	O
PCP	PCP	NN	B-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Greg	Greg	NNP	I-NP	O
Panich	Panich	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Khalil	Khalil	NNP	I-NP	O
--	--	:	O	O
FAMILY	FAMILY	NNP	B-NP	O
:	:	:	O	O
Son	Son	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
radiologist	radiologist	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
894-243-7759	894-243-7759	CD	I-NP	O
,	,	,	O	O
wife	wife	NN	B-NP	O
294-132-4715	294-132-4715	CD	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Hello	Hello	NNP	B-NP	O
Mr.	Mr.	NNP	I-NP	O
Lockner	Lockner	NNP	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
pleasure	pleasure	NN	I-NP	O
taking	take	VBG	B-VP	O
care	care	NN	B-NP	O
of	of	IN	B-PP	O
you	you	PRP	B-NP	O
while	while	IN	B-SBAR	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
you	you	PRP	B-NP	O
know	know	VBP	B-VP	O
,	,	,	O	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
helped	help	VBD	B-VP	O
you	you	PRP	B-NP	O
by	by	IN	B-PP	O
getting	get	VBG	B-VP	O
rid	rid	JJ	B-ADJP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
excess	excess	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
from	from	IN	B-PP	O
your	your	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
slowed	slow	VBD	B-VP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
down	down	RB	B-ADVP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
started	start	VBD	B-VP	O
you	you	PRP	B-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
antiarrhythmic	antiarrhythmic	JJ	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
amiodarone	amiodarone	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
to	to	TO	B-VP	O
try	try	VB	I-VP	O
to	to	TO	I-VP	O
convert	convert	VB	I-VP	O
you	you	PRP	B-NP	O
into	into	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
discharge	discharge	NN	B-NP	O
please	please	NN	I-NP	O
continue	continue	VBP	B-VP	O
taking	take	VBG	I-VP	O
your	your	PRP$	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
please	please	VB	B-VP	O
following	follow	VBG	B-PP	O
these	these	DT	B-NP	O
instructions	instruction	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Weigh	Weigh	VB	B-VP	O
yourself	yourself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
-LRB-	-LRB-	VBP	B-VP	O
your	your	PRP$	B-NP	O
current	current	JJ	I-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
200	200	CD	B-NP	O
pounds	pound	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
gain	gain	VBP	B-VP	O
significant	significant	JJ	B-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
or	or	CC	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
-LRB-	-LRB-	FW	I-NP	O
e.g.	e.g.	FW	I-NP	O
>	>	SYM	I-NP	O
3-5	3-5	CD	I-NP	O
pounds	pound	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
fluid	fluid	JJ	B-NP	O
building	building	NN	I-NP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Please	Please	NN	B-NP	B-protein
taking	take	VBG	B-VP	O
measures	measure	NNS	B-NP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
smoking	smoking	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Please	Please	VB	B-VP	O
check	check	VB	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
everyday	everyday	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
before	before	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	O	O
record	record	VB	B-VP	O
these	these	DT	B-NP	O
values	value	NNS	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Please	Please	VB	B-VP	O
see	see	VB	I-VP	O
an	an	DT	B-NP	O
opthalmologist	opthalmologist	NN	I-NP	O
within	within	IN	B-PP	O
1-2	1-2	CD	B-NP	O
months	month	NNS	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
check-up	check-up	NN	I-NP	B-protein
.	.	.	O	O

5	5	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Please	Please	VB	B-VP	O
continue	continue	VB	I-VP	O
taking	take	VBG	I-VP	O
ezetimibe	ezetimibe	NN	B-NP	O
and	and	CC	I-NP	O
pravastatin	pravastatin	NN	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Please	Please	VB	B-VP	O
see	see	VB	I-VP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
your	your	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
doctor	doctor	NN	I-NP	O
soon	soon	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
6	6	CD	B-NP	O
mg	mg	NN	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
a	a	DT	B-NP	O
night	night	NN	I-NP	O
and	and	CC	O	O
get	get	VB	B-VP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Free	Free	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
clinic	clinic	NN	I-NP	O
on	on	IN	B-PP	O
7/11/06	7/11/06	CD	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
will	will	MD	B-VP	O
then	then	RB	I-VP	O
instruct	instruct	VB	I-VP	O
you	you	PRP	B-NP	O
to	to	TO	B-VP	O
change	change	VB	I-VP	O
your	your	PRP$	B-NP	O
dose	dose	NN	I-NP	O
accordingly	accordingly	RB	B-ADVP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	B-protein
goal	goal	NN	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
2-3	2-3	CD	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Satisfactory	Satisfactory	JJ	B-ADJP	O
TO	TO	TO	B-VP	O
DO/PLAN	DO/PLAN	NN	I-VP	B-DNA
:	:	:	O	I-DNA
1	1	CD	B-NP	I-DNA
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Cardiology	Cardiology	NNP	B-NP	O
--	--	:	O	O
consider	consider	VB	B-VP	O
electric	electric	JJ	B-NP	O
cardioversion	cardioversion	NN	I-NP	O
in	in	IN	B-PP	O
4-6	4-6	CD	B-NP	O
weeks	week	NNS	I-NP	O
if	if	IN	B-SBAR	O
still	still	RB	B-ADVP	O
not	not	RB	O	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
check	check	NN	I-NP	O
LFTs	LFT	NNS	I-NP	O
,	,	,	O	O
PFTs	PFT	NNS	B-NP	B-protein
,	,	,	O	O
TFTs	TFT	NNS	B-NP	B-protein
-LRB-	-LRB-	VBP	B-VP	O
last	last	JJ	B-NP	O
value	value	NN	I-NP	O
10/15/06	10/15/06	CD	B-NP	O
nl	nl	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Primary	Primary	JJ	B-NP	O
care	care	NN	I-NP	O
--	--	:	O	O
titrate	titrate	NN	B-NP	O
hypoglycemics	hypoglycemic	NNS	I-NP	O
--	--	:	O	O
consider	consider	VB	B-VP	O
switching	switch	VBG	I-VP	O
from	from	IN	B-PP	O
glyburide	glyburide	NN	B-NP	O
to	to	TO	B-VP	O
glipizide	glipizide	VB	I-VP	O
given	give	VBN	I-VP	O
renal	renal	JJ	B-NP	O
dyxfxn	dyxfxn	NN	I-NP	O
?	?	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Coumadin	Coumadin	NN	B-NP	O
--	--	:	O	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
2-3	2-3	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
managed	manage	VBN	I-VP	O
at	at	IN	B-PP	O
SBMH	SBMH	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
CLABO	CLABO	NN	B-NP	B-protein
,	,	,	O	O
THAD	THAD	NNP	B-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H	M.P.H	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PC96	PC96	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10/4/06	10/4/06	CD	I-NP	O
@	@	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
55	55	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

